Santen Pharmaceutical Co., Ltd. (SNPHY)
Santen Pharmaceutical Market Cap : 4.077B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.077B |
| November 12, 2026 | 4.032B |
| November 11, 2026 | 4.077B |
| November 10, 2026 | 4.077B |
| November 09, 2026 | 4.077B |
| November 06, 2026 | 3.845B |
| November 05, 2026 | 4.074B |
| November 04, 2026 | 3.687B |
| November 03, 2026 | 3.648B |
| November 02, 2026 | 3.686B |
| October 30, 2026 | 3.608B |
| October 29, 2026 | 3.462B |
| October 28, 2026 | 3.536B |
| October 27, 2026 | 3.594B |
| October 26, 2026 | 3.658B |
| October 23, 2026 | 3.594B |
| October 22, 2026 | 3.459B |
| October 21, 2026 | 3.596B |
| October 20, 2026 | 3.649B |
| October 19, 2026 | 3.536B |
| October 16, 2026 | 3.500B |
| October 15, 2026 | 3.482B |
| October 14, 2026 | 3.504B |
| October 13, 2026 | 3.513B |
| October 12, 2026 | 3.318B |
| Date | Value |
|---|---|
| October 09, 2026 | 3.435B |
| October 08, 2026 | 3.421B |
| October 07, 2026 | 3.434B |
| October 06, 2026 | 3.286B |
| October 05, 2026 | 3.430B |
| October 02, 2026 | 3.389B |
| October 01, 2026 | 3.572B |
| September 30, 2026 | 3.483B |
| September 29, 2026 | 3.387B |
| September 28, 2026 | 3.499B |
| September 25, 2026 | 3.549B |
| September 24, 2026 | 3.453B |
| September 23, 2026 | 3.488B |
| September 22, 2026 | 3.536B |
| September 21, 2026 | 3.514B |
| September 18, 2026 | 3.562B |
| September 17, 2026 | 3.674B |
| September 16, 2026 | 3.437B |
| September 15, 2026 | 3.588B |
| September 14, 2026 | 3.593B |
| September 11, 2026 | 3.620B |
| September 10, 2026 | 3.507B |
| September 09, 2026 | 3.750B |
| September 08, 2026 | 3.694B |
| September 04, 2026 | 3.768B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 68.47B |
| Daiichi Sankyo Co., Ltd. | 32.74B |
| Eisai Co., Ltd. | 9.157B |
| Chugai Pharmaceutical Co., Ltd. | 74.07B |
| Ono Pharmaceutical Co., Ltd. | 7.277B |
Market Cap Related Metrics
| PE Ratio | 16.60 |
| PS Ratio | 2.172 |
| PEG Ratio | 0.7139 |
| Price to Book Value | 2.105 |
| Price to Free Cash Flow | 17.59 |
| Price | 12.67 |
| Earnings Yield | 6.02% |
| PEGY Ratio | 0.7139 |
| Operating PE Ratio | 13.78 |